scholarly journals Objective assessment of visual pursuit in patients with disorders of consciousness: an exploratory study

2017 ◽  
Vol 264 (5) ◽  
pp. 928-937 ◽  
Author(s):  
Sarah Wannez ◽  
Thomas Hoyoux ◽  
Thomas Langohr ◽  
Olivier Bodart ◽  
Charlotte Martial ◽  
...  
Keyword(s):  
Exploratory Study ◽  
Objective Assessment ◽  
Disorders Of Consciousness ◽  
Visual Pursuit

Towards consensus on visual pursuit and visual fixation in patients with disorders of consciousness. A Delphi study

2022 ◽  
Author(s):  
Berno U. H. Overbeek ◽  
Jan C. M. Lavrijsen ◽  
Simon van Gaal ◽  
Daniel Kondziella ◽  
Henk J. Eilander ◽  
...  
Keyword(s):  
Delphi Study ◽  
Visual Fixation ◽  
Disorders Of Consciousness ◽  
Visual Pursuit

Simultaneous EEG–PET–fMRI measurements in disorders of consciousness: an exploratory study on diagnosis and prognosis

2017 ◽  
Vol 264 (9) ◽  
pp. 1986-1995 ◽  
Author(s):  
Daniel Golkowski ◽  
Katharina Merz ◽  
Caroline Mlynarcik ◽  
Tobias Kiel ◽  
Barbara Schorr ◽  
...  
Keyword(s):  
Exploratory Study ◽  
Disorders Of Consciousness ◽  
Diagnosis And Prognosis

Visual pursuit of one’s own face in disorders of consciousness: a quantitative analysis

Brain Injury ◽  
2018 ◽  
Vol 32 (12) ◽  
pp. 1549-1555 ◽  
Author(s):  
Luigi Trojano ◽  
Pasquale Moretta ◽  
Orsola Masotta ◽  
Vincenzo Loreto ◽  
Anna Estraneo
Keyword(s):  
Quantitative Analysis ◽  
Disorders Of Consciousness ◽  
Visual Pursuit

98. Quantitative assessment of visual pursuit of salient stimuli in Disorders of Consciousness

2013 ◽  
Vol 124 (11) ◽  
pp. e211
Author(s):  
A. Estraneo ◽  
P. Moretta ◽  
L. Trojano ◽  
V. Loreto ◽  
L. Santoro
Keyword(s):  
Quantitative Assessment ◽  
Disorders Of Consciousness ◽  
Visual Pursuit

scholarly journals Why use a mirror to assess visual pursuit in prolonged disorders of consciousness? Evidence from healthy control participants

BMC Neurology ◽  
2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Damian Cruse ◽  
Marco Fattizzo ◽  
Adrian M. Owen ◽  
Davinia Fernández-Espejo
Keyword(s):  
Disorders Of Consciousness ◽  
Visual Pursuit ◽  
Healthy Control

scholarly journals Immunomodulatory Effect of Charak Immunity Tablets (CIT) On Healthy Participants: A Single Blind, Randomized, Placebo-Controlled, Exploratory Study

2021 ◽  
Author(s):  
Akanksha Mourya ◽  
Amit Yadav ◽  
Suresh Khadke ◽  
Sarika Mane ◽  
Asavari Joshi ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Perceived Stress ◽  
Exploratory Study ◽  
Mononuclear Cells ◽  
Immune Status ◽  
Respiratory Health ◽  
Objective Assessment ◽  
Healthy Individuals ◽  
Single Blind

Immunity has become an important aspect of concern, as the spread of corona virus, is on the rise. The strategies to boost and modulate the immunity have therefore become need of the hour. The present study was carried out to evaluate the effect of Charak immunity Tablets (CIT) on innate and adaptive immune response in healthy individuals. It was a single-blind, randomized, placebo-controlled, exploratory study. After obtaining Ethics Committee permission, 36 healthy individuals of either sex aged 18-35 years with prior consent were recruited in the study. They were randomly divided into 2 groups to receive either CIT or Placebo in 2:1 ratio. Both the interventions were given in a dose of 1 tab (500 mg) twice daily. The assessment variables were vitals [temperature, pulse, and blood pressure], respiratory health [respiratory rate, oxygen saturation and peak expiratory flow rate], questionnaire based assessment of immune status, perceived stress and quality of life along with objective assessment of immunity [CD4+, CD8+ counts, Interferon gamma (IFN γ), Tumor necrosis factor alpha (TNF-α) and Interleukin 10 (IL-10)] as well as oxidative stress; [Malondialdehyde (MDA) and Glutathione peroxidase], which were assessed at fixed time points. Of 36 recruited participants, only 18 participants completed the study. CIT treated individuals showed a statistically significant improvement in respiratory health, quality of life, perceived stress and subjective immune status. There was a decrease in the levels of serum IFN γ on day 60 compared to baseline. TNF-α and IL-10, both estimated from supernatant of Peripheral Blood Mononuclear Cells (PBMCs) stimulated with lipopolysaccharide (LPS), showed a decrease and a significant increase respectively on day 60 compared to baseline in CIT group. Further, CIT significantly decreased MDA levels.The present study indicates that CIT is an effective and safe drug to boost immunity. However, our findings need to be confirmed in larger sample size using more specific immune parameters.

Sign in / Sign up

Export Citation Format

Share Document